Cargando…
Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762752/ https://www.ncbi.nlm.nih.gov/pubmed/29333418 http://dx.doi.org/10.5045/br.2017.52.4.337 |
_version_ | 1783291754970087424 |
---|---|
author | Moon, Ji Young Jo, Deog-Yeon Lee, So Yeon Kim, Deok Yeong Baek, Seung-Woo Song, Ik-Chan |
author_facet | Moon, Ji Young Jo, Deog-Yeon Lee, So Yeon Kim, Deok Yeong Baek, Seung-Woo Song, Ik-Chan |
author_sort | Moon, Ji Young |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5762752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
record_format | MEDLINE/PubMed |
spelling | pubmed-57627522018-01-12 Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab Moon, Ji Young Jo, Deog-Yeon Lee, So Yeon Kim, Deok Yeong Baek, Seung-Woo Song, Ik-Chan Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2017-12 2017-12-26 /pmc/articles/PMC5762752/ /pubmed/29333418 http://dx.doi.org/10.5045/br.2017.52.4.337 Text en © 2017 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Moon, Ji Young Jo, Deog-Yeon Lee, So Yeon Kim, Deok Yeong Baek, Seung-Woo Song, Ik-Chan Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab |
title | Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab |
title_full | Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab |
title_fullStr | Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab |
title_full_unstemmed | Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab |
title_short | Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab |
title_sort | low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762752/ https://www.ncbi.nlm.nih.gov/pubmed/29333418 http://dx.doi.org/10.5045/br.2017.52.4.337 |
work_keys_str_mv | AT moonjiyoung lowdoseprednisoloneinpatientswithparoxysmalnocturnalhemoglobinuriaandinadequateresponsetoeculizumab AT jodeogyeon lowdoseprednisoloneinpatientswithparoxysmalnocturnalhemoglobinuriaandinadequateresponsetoeculizumab AT leesoyeon lowdoseprednisoloneinpatientswithparoxysmalnocturnalhemoglobinuriaandinadequateresponsetoeculizumab AT kimdeokyeong lowdoseprednisoloneinpatientswithparoxysmalnocturnalhemoglobinuriaandinadequateresponsetoeculizumab AT baekseungwoo lowdoseprednisoloneinpatientswithparoxysmalnocturnalhemoglobinuriaandinadequateresponsetoeculizumab AT songikchan lowdoseprednisoloneinpatientswithparoxysmalnocturnalhemoglobinuriaandinadequateresponsetoeculizumab |